VGM & ASSOCIATESHealthcare MSO
Full Menu Search

VGM Submits Comments Regarding the Section 232 National Security Investigation On Medical Imports

Published in Government Relations on October 09, 2025

VGM has submitted formal comments to the U.S. Department of Commerce in response to its Section 232 National Security Investigation into the importation of personal protective equipment (PPE), medical consumables, and medical equipment and devices. 

While we recognize the importance of strengthening domestic supply chains and safeguarding national security, VGM emphasized that any resulting trade restrictions must be carefully considered to avoid unintended harm to the durable medical equipment (DME) industry and the patients it serves. 

The submitted comments outlined below include several significant challenges that the DME industry could face if the investigation leads to increased trade restrictions: 

  1. Tariffs and Cost Increases. If new tariffs are imposed on imported medical equipment and components, manufacturers will experience immediate cost hikes. Many essential parts, used in products like wheelchairs, ventilators, and hospital beds, are sourced internationally due to cost and availability. These tariffs could raise production costs, reduce affordability, and limit access for patients and providers. 
  2. Supply Chain Disruption. The DME industry depends on a global supply chain to deliver timely and diverse products. Trade restrictions or tariffs could disrupt this system, causing delays, shortages, and uncertainty, especially critical items like prosthetics, insulin pumps, and glucose monitors that are vital to patient health. 
  3. Limited Domestic Manufacturing Capacity. While boosting domestic production is a worthy goal, current U.S. infrastructure cannot quickly scale to meet demand across all DME categories. Moving away from foreign suppliers without viable domestic alternatives could lead to service gaps. Any shift must consider realistic timelines, investment needs, and workforce readiness. 
  4. Impact on Patient Care and Providers. Higher costs and reduced access to DME products will directly affect patient outcomes. Providers may have to cut services, delay treatments, or pass costs onto patients, undermining healthcare resilience and compromising care quality. 
  5. Risk of Unintended Consequences. Efforts to reduce foreign dependency must be carefully tailored. Broad, one-size-fits-all policies could unintentionally harm U.S. manufacturers who rely on global inputs, stifle innovation, and reduce competitiveness. 

VGM urges the Department of Commerce to take a balanced, collaborative approach that protects national interests without compromising patient care or destabilizing the DME industry. We encourage policymakers to engage with stakeholders across the healthcare continuum to ensure that any future policies support both supply chain resilience and the continued delivery of high-quality, affordable medical equipment to those who need it most.

To submit comments and review the full Section 232 National Security Investigation notice, go to the Federal Rulemaking Portal. 

Get Connected

Stay up-to-date on the latest resources and news provided by VGM & Associates.

Sign Up for Email

From Our Experts

Major Update On Product Categories For The Next Round Of Competitive Bidding thumbnail Major Update On Product Categories For The Next Round Of Competitive Bidding Since the publication of the Final Rules on the Competitive Bidding Program (CBP) was announced, VGM has been in conversation with CMS officials as well as other industry groups regarding additional products being included into the CBP. The unofficial feedback we received indicated that there would be no additional products beyond those reported in the Final Rule. CMS Finalizes Rule Changing The Next Round Of The Competitive Bidding Program And Updating Other Provisions Related To Provider Enrollment And Prior Authorization thumbnail CMS Finalizes Rule Changing The Next Round Of The Competitive Bidding Program And Updating Other Provisions Related To Provider Enrollment And Prior Authorization Final Rule Analysis from the VGM Payer Relations and Reimbursement team  On Nov, 28, 2025, CMS finalized Final Rule CMS-1828-F that includes updates to the Competitive Bidding Program (CBP) and other provisions related to provider enrollment and prior authorization. Next round is expected to be implemented no later than Jan. 1, 2028. Celebrating the Life and Impact of Mike Hamilton, ADMEA Executive Director thumbnail Celebrating the Life and Impact of Mike Hamilton, ADMEA Executive Director We are deeply saddened to share the passing of our beloved colleague and friend, Mike Hamilton, Executive Director of the Alabama Durable Medical Equipment Association (ADMEA). For more than 50 years, Mike dedicated his life to the durable medical equipment (DME) industry, setting an extraordinary example of hard work, integrity, and unwavering passion. His leadership and advocacy helped shape the industry and improve access to care for countless patients. The Big Sky Association of Medical Equipment Suppliers Welcomes UTAH! thumbnail The Big Sky Association of Medical Equipment Suppliers Welcomes UTAH! The Big Sky Association of Medical Equipment Suppliers is pleased to announce that Utah has officially been accepted into the association as our newest participating state. Big Sky now proudly welcomes all Utah DME/HME, Respiratory, CRT, and Medical Supply companies into our regional association. Utah will have a designated state representative/director—appointed in the same manner as Montana, Idaho, and Wyoming—to ensure strong representation and a clear voice within the Association. Beyond the Shutdown and The Proposed Rule: Key Legislative Updates for the HME Industry thumbnail Beyond the Shutdown and The Proposed Rule: Key Legislative Updates for the HME Industry While the government shutdown and uncertainty surrounding CMS's Proposed Rule have dominated headlines, several important bills impacting HME providers continue to advance. Here's a quick look at three focused legislative priorities: Advocacy in Action: Texas DME Providers Stand Up For Patient Care thumbnail Advocacy in Action: Texas DME Providers Stand Up For Patient Care Texas DME providers are speaking out against proposed Medicaid reimbursement rate cuts that threaten access to essential medical equipment for vulnerable patients. At a recent public hearing, voices from across the state shared powerful stories about the real-world impact of these cuts—some as high as 85%. The Shutdown Has Ended—Now It's Time To Take Action thumbnail The Shutdown Has Ended—Now It's Time To Take Action The recent government shutdown created uncertainty across the healthcare landscape, and the DMEPOS community was no exception. In the weeks ahead, critical decisions will shape the future of our industry. By getting involved early—through advocacy, education, and collaboration—you can help ensure these policies support patients and providers rather than hinder them. Notably, the Continuing Resolution (CR) includes an extension of Medicare telehealth flexibilities through January 2026... New Issue Brief: Why Medicare's Competitive Bidding Program Needs Urgent Reform thumbnail New Issue Brief: Why Medicare's Competitive Bidding Program Needs Urgent Reform The Medicare competitive bidding program for durable medical equipment (DME) was designed to reduce costs—but it's failing patients and providers. A new issue brief from Pacific Research Institute and economist Wayne Winegarden highlights what changes are urgently needed.

Give your business an advantage over the competition.

Become a Member